Nyxoah S.A. (NASDAQ:NYXH) Sees Large Increase in Short Interest

Nyxoah S.A. (NASDAQ:NYXH - Get Free Report) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 177,800 shares, a growth of 45.5% from the May 15th total of 122,200 shares. Currently, 1.0% of the company's shares are sold short. Based on an average daily volume of 167,200 shares, the days-to-cover ratio is currently 1.1 days.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on NYXH shares. Stifel Nicolaus dropped their price target on Nyxoah from $15.00 to $14.00 and set a "buy" rating on the stock in a research report on Monday, April 21st. HC Wainwright reissued a "buy" rating and set a $15.00 target price on shares of Nyxoah in a research report on Tuesday, April 8th.

Nyxoah Stock Up 2.8%

Shares of NASDAQ NYXH traded up $0.21 during mid-day trading on Monday, reaching $7.75. 19,772 shares of the company were exchanged, compared to its average volume of 75,461. Nyxoah has a 1 year low of $5.55 and a 1 year high of $11.87. The firm has a 50-day moving average of $6.75 and a 200 day moving average of $8.45. The stock has a market cap of $263.97 million, a price-to-earnings ratio of -4.14 and a beta of 1.65. The company has a quick ratio of 4.95, a current ratio of 5.28 and a debt-to-equity ratio of 0.21.

Nyxoah (NASDAQ:NYXH - Get Free Report) last released its quarterly earnings results on Wednesday, May 14th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.14). The firm had revenue of $1.12 million for the quarter, compared to analysts' expectations of $1.64 million. Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%. On average, research analysts expect that Nyxoah will post -1.91 earnings per share for the current year.

Hedge Funds Weigh In On Nyxoah

Several institutional investors and hedge funds have recently bought and sold shares of NYXH. LPL Financial LLC acquired a new stake in shares of Nyxoah in the 4th quarter worth $102,000. Walleye Capital LLC raised its stake in Nyxoah by 23.9% in the fourth quarter. Walleye Capital LLC now owns 14,831 shares of the company's stock valued at $119,000 after buying an additional 2,862 shares during the last quarter. Ameriprise Financial Inc. acquired a new stake in Nyxoah in the fourth quarter worth about $135,000. Geode Capital Management LLC grew its stake in shares of Nyxoah by 19.4% during the fourth quarter. Geode Capital Management LLC now owns 17,100 shares of the company's stock worth $137,000 after acquiring an additional 2,774 shares during the last quarter. Finally, Kovack Advisors Inc. increased its holdings in shares of Nyxoah by 100.0% during the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company's stock valued at $160,000 after acquiring an additional 10,000 shares in the last quarter.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.